Comparison of [F-18]altanserin and [F-18]deuteroaltanserin for PET imagingof serotonin(2A) receptors in baboon brain: pharmacological studies

Citation
Jk. Staley et al., Comparison of [F-18]altanserin and [F-18]deuteroaltanserin for PET imagingof serotonin(2A) receptors in baboon brain: pharmacological studies, NUCL MED BI, 28(3), 2001, pp. 271-279
Citations number
44
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
NUCLEAR MEDICINE AND BIOLOGY
ISSN journal
09698051 → ACNP
Volume
28
Issue
3
Year of publication
2001
Pages
271 - 279
Database
ISI
SICI code
0969-8051(200104)28:3<271:CO[A[F>2.0.ZU;2-7
Abstract
The regional distribution in brain, distribution volumes, and pharmacologic al specificity of the PET 5-HT2A receptor radiotracer [F-18]deuteroaltanser in were evaluated and compared to those of its non-deuterated derivative [F -18]altanserin. Both radiotracers were administered to baboons by bolus plu s constant infusion and PET images were acquired up to 8 h. The time-activi ty curves for both tracers stabilized between 4 and 6 h. The ratio of total and free parent to metabolites was not significantly different between rad iotracers; nevertheless, total cortical R-T (equilibrium ratio of specific to nondisplaceable brain uptake) was significantly higher (34-78%) for [F-1 8]deuteroaltanserin than for [F-18]altanserin. In contrast, the binding pot ential (B-max/K-D) was similar between radiotracers. [F-18]Deuteroaltanseri n cortical activity was displaced by the 5-HT2A receptor antagonist SR 4634 9B but was not altered by changes in endogenous 5-HT induced by fenfluramin e. These findings suggest that [F-18]deuteroaltanserin is essentially equiv alent to [F-18]altanserin for 5-HT2A receptor imaging in the baboon. (C) 20 01 Elsevier Science Inc. All rights reserved.